Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection†‡Richard K. Sterling, Mark Nelson, David L. Thomas et al.|Hepatology|2006Cited by 4.8k
Efficacy of Enfuvirtide in Patients Infected with Drug-Resistant HIV-1 in Europe and AustraliaAdriano Lazzarin, Miklos Salgo, Bonaventura Clotet et al.|New England Journal of Medicine|2003Cited by 653
Durable Efficacy of Enfuvirtide Over 48 Weeks in Heavily Treatment-Experienced HIV-1-Infected Patients in the T-20 Versus Optimized Background Regimen Only 1 and 2 Clinical TrialsMark Nelson, Miklos Salgo, Keikawus Arastéh et al.|JAIDS Journal of Acquired Immune Deficiency Syndromes|2005Cited by 151
Computational models can predict response to HIV therapy without a genotype and may reduce treatment failure in different resource-limited settingsA. D. Revell, D. Wang, Robin Wood et al.|Journal of Antimicrobial Chemotherapy|2013Cited by 34
Myths and Facts Regarding Low-Carbohydrate DietsNina Teicholz, Susan Wolver, Steven M. Croft et al.|Nutrients|2025Cited by 8